If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it ...

Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of ...

Targeting IL-18BP to Boost Immunity. Graphical Abstract ©ArnaudHUARD/UNIGE. SUMMARY. Interleukin (IL)-18 is an immunoregulatory cytokine that acts as a potent inducer of T helper ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Therefore, Invivyd does not anticipate any meaningful change to pemivibart neutralization activity, aside from expected normal quantitative variation in assay output, for the foreseeable future if ...

"We show that two long-acting broadly neutralizing antibodies can tend to maintain ... can neutralize more broadly across HIV ...

Bispecific antibodies, engineered to bind two distinct ... and biolayer interferometry. Pseudovirus neutralization assays were performed to evaluate its ability to prevent viral entry into host ...

cLIA and hemagglutination inhibition are surrogate assays for measuring the presence of neutralizing antibodies; cLIA: Competitive luminex immunoassay; PBNA: Pseudovirion-based neutralization assay.